Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients

被引：0
|
作者：
Johannes Heide
Silvia Ribback
Tobias Klatte
Shahrokh Shariat
Martin Burchardt
Frank Dombrowski
Arie S. Belldegrun
Alexandra Drakaki
Allan J. Pantuck
Nils Kroeger
机构：
[1] University Medicine at the Ernst-Moritz-Arndt-University Greifswald,Department of Urology
[2] F. Sauerbruch Str,Department of Urology
[3] Medical University of Vienna,Department of Surgery
[4] University of Cambridge,Department of Urology
[5] Royal Bournemouth and Christchurch Hospitals National Health Services Dorset,Institute of Pathology
[6] University Medicine at the Ernst-Moritz-Arndt-University Greifswald,Department of Urology at the David Geffen
[7] University of California Los Angeles,School of Medicine, Institute of Urologic Oncology
[8] University of California Los Angeles,Division of Hematology/Oncology, Department of Medicine at the David Geffen
来源：
World Journal of Urology | 2020年 / 38卷
关键词：
Renal cell carcinoma; Co-morbidities; Hypertension; Co-morbidities; Anti-hypertensive medication; Statins; Prognostic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1525 / 1533
页数：8
相关论文
共 50 条
  • [1] Evaluation of the prognostic role of co-morbidities on disease outcome in renal cell carcinoma patients
    Heide, Johannes
    Ribback, Silvia
    Klatte, Tobias
    Shariat, Shahrokh
    Burchardt, Martin
    Dombrowski, Frank
    Belldegrun, Arie S.
    Drakaki, Alexandra
    Pantuck, Allan J.
    Kroeger, Nils
    WORLD JOURNAL OF UROLOGY, 2020, 38 (06) : 1525 - 1533
  • [2] Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities
    Young, Robert P.
    Hopkins, Raewyn J.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (05) : 533 - 544
  • [3] Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients
    Elbuluk, Nada
    Ezzedine, Khaled
    DERMATOLOGIC CLINICS, 2017, 35 (02) : 117 - +
  • [4] Complications and renal functional deterioration in patients with co-morbidities following laparoscopic partial nephrectomy
    Sharma, E.
    Chally, P. R.
    Santhosh, S.
    Ratkal, J. M.
    AFRICAN JOURNAL OF UROLOGY, 2016, 22 (03) : 162 - 167
  • [5] Statins May Prevent Atherosclerotic Disease in OSA Patients without Co-Morbidities?
    Toraldo, Domenico Maurizio
    De Benedetto, Michele
    Conte, Luana
    De Nuccio, Francesco
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (01) : 5 - 9
  • [6] Impact of coronavirus disease 2019 on co-morbidities in HIV
    Guaraldi, Giovanni
    Milic, Jovana
    CURRENT OPINION IN HIV AND AIDS, 2023, 18 (02) : 111 - 115
  • [7] The impact of co-morbidities on the wealth of people with heart disease
    Schofield, Deborah J.
    Callander, Emily J.
    Shrestha, Rupendra N.
    Passey, Megan E.
    Kelly, Simon J.
    Percival, Richard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 169 (01) : E12 - E13
  • [8] Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
    Ahmed, Maryam
    Leech, Karen
    Rickard, Barbara
    Lynch, Carol
    Owen, Gill
    Kempson, Wayne
    Allen, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [9] Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease
    Areias, V.
    Carreira, S.
    Anciaes, M.
    Pinto, P.
    Barbara, C.
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2014, 20 (01) : 5 - 11
  • [10] IMPORTANCE OF PREEXISTING CO-MORBIDITIES FOR PROGNOSIS OF SEPTICEMIA IN CRITICALLY ILL PATIENTS
    PITTET, D
    THIEVENT, B
    WENZEL, RP
    LI, N
    GURMAN, G
    SUTER, PM
    INTENSIVE CARE MEDICINE, 1993, 19 (05) : 265 - 272
12345